-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NWrzcJwzTcTTm/ypDVBoxb7TifCzguAataL5k79bCP5XlSmkMfL1tMxWVTS2In0S GsEbgaiJSEI39I+qxwQaKA== 0000914062-02-000143.txt : 20020414 0000914062-02-000143.hdr.sgml : 20020414 ACCESSION NUMBER: 0000914062-02-000143 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20020214 GROUP MEMBERS: JOHN N. KAPOOR TRUST DTD 9/20/89 GROUP MEMBERS: JOHN N. KAPOOR, PH.D. GROUP MEMBERS: KAPOOR PHARMA INVESTMENTS, L.P. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: FIRST HORIZON PHARMACEUTICAL CORP CENTRAL INDEX KEY: 0001106773 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122] IRS NUMBER: 582004779 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-60977 FILM NUMBER: 02544936 BUSINESS ADDRESS: STREET 1: 660 HEMBREE PARKWAY STREET 2: SUITE 106 CITY: ROSWELL STATE: GA ZIP: 30076 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: KAPOOR JOHN N CENTRAL INDEX KEY: 0001033150 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 225 EAST DEERPATH RD STREET 2: SUITE 250 CITY: LAKE FOREST STATE: IL ZIP: 60045 BUSINESS PHONE: 7704429707 MAIL ADDRESS: STREET 1: 225 E DEERPATH RD STE 250 CITY: LAKE FOREST STATE: IL ZIP: 60045 SC 13G/A 1 kapoor13ga202.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ---------------- SCHEDULE 13G/A INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13-d(1)(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. 2) (1) First Horizon Pharmaceutical Corporation --------------------------------------------- (Name of Issuer) Common Stock, $0.01 par value --------------------------------------------- (Title and Class of Securities) 320 51K 106 --------------------------------------------- (CUSIP Number) December 31, 2001 --------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: | | Rule 13d-1(b) | | Rule 13d-1(c) |X| Rule 13d-1(d) ---------------- (1) The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP NO. 320 51K 106 13G/A Page 2 of 10 ----------- (l) Names of Reporting Persons I.R.S. Identification No. of Above Persons (Entities Only) John N. Kapoor, Ph.D. - -------------------------------------------------------------------------------- (2) Check the Appropriate Box if a Member of a Group (a) x . ----------------- (b) . ----------------- - -------------------------------------------------------------------------------- (3) SEC Use Only - -------------------------------------------------------------------------------- (4) Citizenship or Place of Organization United States - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- Number of (5) Sole Voting Power 9,017,311 (1) Shares ----------------------------------------------------------- Beneficially (6) Shared Voting Power 0 Owned by ----------------------------------------------------------- Each (7) Sole Dispositive Power 9,017,311 (1) Reporting ----------------------------------------------------------- Person With (8) Shared Dispositive Power 0 - -------------------------------------------------------------------------------- (9) Aggregate Amount Beneficially Owned by Each Reporting Person 9,017,311 (1) - -------------------------------------------------------------------------------- (10) Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares X . ----- - -------------------------------------------------------------------------------- (11) Percent of Class Represented by Amount in Row 9 33.3% - -------------------------------------------------------------------------------- (12) Type of Reporting Person IN - -------------------------------------------------------------------------------- CUSIP NO. 320 51K 106 13G/A Page 3 of 10 ----------- (1) Includes 7,753,190 shares held by Kapoor Pharma Investments, L.P., a limited partnership (the "Partnership"). E.J. Financial Enterprises, Inc. is the managing general partner of the Partnership and Mr. Kapoor is the sole stockholder of E.J. Financial Enterprises. The limited partnership interests of the Partnership are held by various family trusts. Includes 1,264,121 shares held by John N. Kapoor Trust dtd 9/20/89, of which Mr. Kapoor is the sole trustee and sole beneficiary. Excludes 155,480 shares held by family trusts of which Mr. Kapoor's spouse is the sole trustee. All share amounts have been adjusted to reflect a three-for-two stock split which was effective on September 24, 2001. CUSIP NO. 320 51K 106 13G/A Page 4 of 10 ----------- (l) Names of Reporting Persons I.R.S. Identification No. of Above Persons (Entities Only) Kapoor Pharma Investments, L.P. - -------------------------------------------------------------------------------- (2) Check the Appropriate Box if a Member of a Group (a) x . ------------------ (b) . ------------------ - -------------------------------------------------------------------------------- (3) SEC Use Only - -------------------------------------------------------------------------------- (4) Citizenship or Place of Organization Delaware - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- Number of (5) Sole Voting Power 7,753,190 (2) Shares ----------------------------------------------------------- Beneficially (6) Shared Voting Power 0 Owned by ----------------------------------------------------------- Each (7) Sole Dispositive Power 7,753,190 (2) Reporting ----------------------------------------------------------- Person With (8) Shared Dispositive Power 0 - -------------------------------------------------------------------------------- (9) Aggregate Amount Beneficially Owned by Each Reporting Person 7,753,190 (2) - -------------------------------------------------------------------------------- (10) Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares . ----- - -------------------------------------------------------------------------------- (11) Percent of Class Represented by Amount in Row 9 28.7% - -------------------------------------------------------------------------------- (12) Type of Reporting Person PN - -------------------------------------------------------------------------------- CUSIP NO. 320 51K 106 13G/A Page 5 of 10 ----------- (2) E.J. Financial Enterprises, Inc. is the managing general partner of the Kapoor Pharma Investments, L.P. (the "Partnership") and Mr. Kapoor is the sole stockholder of E.J. Financial Enterprises. The limited partnership interests of the Partnership are held by various family trusts. All share amounts have been adjusted to reflect a three-for-two stock split which was effective on September 24, 2001. CUSIP NO. 320 51K 106 13G/A Page 6 of 10 ----------- (l) Names of Reporting Persons I.R.S. Identification No. of Above Persons (Entities Only) John N. Kapoor Trust dtd 9/20/89 - -------------------------------------------------------------------------------- (2) Check the Appropriate Box if a Member of a Group (a) x . ------------ (b) . ------------ - -------------------------------------------------------------------------------- (3) SEC Use Only - -------------------------------------------------------------------------------- (4) Citizenship or Place of Organization United States - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- Number of (5) Sole Voting Power 1,264,121 (3) Shares ----------------------------------------------------------- Beneficially (6) Shared Voting Power 0 Owned by ----------------------------------------------------------- Each (7) Sole Dispositive Power 1,264,121 (3) Reporting ----------------------------------------------------------- Person With (8) Shared Dispositive Power 0 - -------------------------------------------------------------------------------- (9) Aggregate Amount Beneficially Owned by Each Reporting Person 1,264,121 (3) - -------------------------------------------------------------------------------- (10) Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares . ------ - -------------------------------------------------------------------------------- (11) Percent of Class Represented by Amount in Row 9 4.7% - -------------------------------------------------------------------------------- (12) Type of Reporting Person OO - -------------------------------------------------------------------------------- (3) Mr. Kapoor is the sole trustee and sole beneficiary of the John N. Kapoor Trust dtd 9/20/89 (the "Trust"). The Trust disclaims shares beneficially owned by Mr. Kapoor and the Partnership. All share amounts have been adjusted to reflect a three-for-two stock split which was effective on September 24, 2001. CUSIP NO. 320 51K 106 13G/A Page 7 of 10 ----------- Item l(a). Name of Issuer: First Horizon Pharmaceutical Corporation Item l(b). Address of Issuer's Principal Executive Offices: 660 Hembree Parkway, Suite 106 Roswell, GA 30076 Item 2(a). Name of Person Filing: See item (l) of the cover pages Item 2(b). Address of Principal Business Office: The principal business office for both reporting persons is 225 East Deerpath, Suite 250, Lake Forest, IL 60045 Item 2(c). Citizenship: See item (4) of cover pages Item 2(d). Title of Class of Securities: Common Stock, $0.01 Par Value Item 2(e). CUSIP Number: 320 51K 106 Item 3. If this statement is filed pursuant to Rule 13-d(1)(b) or 13d-2(b) or (c), check whether the person filing is a: Not applicable Item 4. Ownership. John N. Kapoor is the President and sole stockholder of EJ Financial Enterprises, Inc. which is the managing general partner of Kapoor - Pharma Investments, L.P. As such, the ownership interest of both John N. Kapoor and Kapoor-Pharma Investments, L.P. is as follows: (a) Amount beneficially owned: See item (9) of cover pages CUSIP NO. 320 51K 106 13G/A Page 8 of 10 ----------- (b) Percent of Class: See item (11) of cover pages (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: See item (5) of cover pages (ii) shared power to vote or to direct the vote: See item (6) of cover pages (iii) sole power to dispose or to direct the disposition of: See item (7) of cover pages (iv) shared power to dispose or to direct the disposition of: See item (8) of cover pages Item 5. Ownership of Five Percent or Less of a Class: Not applicable Item 6. Ownership of More than Five Percent on Behalf of Another Person: John N. Kapoor ("Kapoor") is the sole trustee and beneficiary of the John N. Kapoor Trust dtd 9/20/89 (the "Trust") as well as the sole stock holder of E.J. Financial Enterprises. Kapoor Pharma Investments, L.P. (the "Partnership") is a limited partnership organized under the laws of Delaware. E.J. Financial Enterprises, Inc. is the managing general partner of the Partnership. The limited partnership interests of the Partnership are held by various family trusts. The Trust disclaims shares beneficially owned by Kapoor and the Partnership. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person: Not applicable Item 8. Identification and Classification of Members of the Group: The members of the group filing this Schedule 13G/A are John N. Kapoor, Kapoor-Pharma Investments, L.P. and John N. Kapoor Trust dtd 9/20/89. CUSIP NO. 320 51K 106 13G/A Page 9 of 10 ----------- Item 9. Notice of Dissolution of Group: Not applicable Item 10. Certification: Not applicable CUSIP NO. 320 51K 106 13G/A Page 10 of 10 ----------- Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 14, 2002 ________________________________________ (Date) /s/ John N. Kapoor ________________________________________ (Signature) John N. Kapoor, Ph.D. ________________________________________ (Name/Title) February 14, 2002 ________________________________________ (Date) /s/ John N. Kapoor ________________________________________ (Signature) John N. Kapoor, Ph.D., President, EJ Financial Enterprises, Inc., as Managing General Partner of Kapoor-Pharma Investments, L.P. _________________________________________ (Name/Title) February 14, 2002 ________________________________________ (Date) /s/ John N. Kapoor ________________________________________ (Signature) John N. Kapoor, Ph.D., Trustee, John N. Kapoor Trust dtd 9/20/89 _________________________________________ (Name/Title) 1324244v2 -----END PRIVACY-ENHANCED MESSAGE-----